| Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd. Gold
|
| Tel: |
18818260767 |
| Email: |
sales@chemegen.com |
| Products Intro: |
Product Name:Ataciguat
CAS:254877-67-3
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
|
| | Ataciguat Basic information |
| Product Name: | Ataciguat | | Synonyms: | 5-Chloro-2-[[(5-chloro-2-thienyl)sulfonyl]amino]-N-[4-(4-morpholinylsulfonyl)phenyl]benzamide;Ataciguat;HMR 1766;Benzamide, 5-chloro-2-[[(5-chloro-2-thienyl)sulfonyl]amino]-N-[4-(4-morpholinylsulfonyl)phenyl]-;Ataciguat
(HMR-1766;cyclase,soluble,HMR 1766,Ataciguat,Guanylate Cyclase,Inhibitor,sGC,inhibit,HMR1766,vasodilator,cGMP,guanylate;5-Chloro-2-(5-chlorothiophene-2-sulfonamido)-N-(4-(morpholinosulfonyl)phenyl)benzamide | | CAS: | 254877-67-3 | | MF: | C21H19Cl2N3O6S3 | | MW: | 576.5 | | EINECS: | | | Product Categories: | Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds;Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds | | Mol File: | 254877-67-3.mol |  |
| | Ataciguat Chemical Properties |
| density | 1.613±0.06 g/cm3(Predicted) | | solubility | DMF: 1 mg/ml; DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml | | form | A crystalline solid | | pka | 5.70±0.50(Predicted) |
| | Ataciguat Usage And Synthesis |
| Uses | Ataciguat, formerly referred to as HMR-1766, a novel anthranilic acid derivative, belongs to a new structural class of sGC activators capable of activating the oxidized form of sGC. Ataciguat has been shown to improve endothelial function and to reduce platelet activation in exptl. diabetes. Chronic regular treatment with sGC activators such as ataciguat could therefore eventually constitute an effective therapy targeting deficient NO/cGMP signaling in hypertension, peripheral and coronary artery disease, heart failure, thrombosis and erectile dysfunction. |
| | Ataciguat Preparation Products And Raw materials |
|